MSDS

Bayer Environmental Science
Material Safety Data Sheet
MSDS Number: 102000011911
BAYER ADVANCED COMPLETE BRAND INSECT KILLER
FOR SOIL & TURF READY-TO-SPREAD GRANULES
MSDS Version 1.0
Page 5 of 7
local or systemic effects at levels up to and including 1000 mg/kg, the limit dose.
In a 4-week inhalation study, rats exposed to high concentrations of imidacloprid
exhibited decreased body weight gains and changes in clinical chemistries and
organ weights.
Chronic Toxicity
IMIDACLOPRID TECHNICAL
In chronic dietary studies in rats and dogs exposed to imidacloprid, the target
organs were the thyroids and/or liver.
Assessment Carcinogenicity
IMIDACLOPRID TECHNICAL
In oncogenicity studies in rats and mice, imidacloprid was not considered carcinogenic in either species.
ACGIH
Wood dust Group A1
NTP
Wood dust
IARC
Wood dust Overall evaluation: 1
OSHA
None.
Reproductive &
Developmental Toxicity
BETA-CYFLUTHRIN TECHNICAL
DEVELOPMENTAL TOXICITY: In an oral developmental toxicity study in rats
treated with beta cyfluthrin, decreased fetal body weights and an increased
incidence of skeletal findings were observed at the maternally toxic and lethal
high dose level (40 mg/kg).
IMIDACLOPRID TECHNICAL
DEVELOPMENTAL TOXICITY: In developmental toxicity studies in rats and
rabbits, there was no evidence of an embryotoxic or teratogenic potential for
imidacloprid. In both species, developmental effects were observed only at high
doses and in conjunction with maternal toxicity.
REPRODUCTION: In a two-generation reproduction study in rats, imidacloprid
was not a primary reproductive toxicant. Offspring exhibited reduced body
weights at the high dose and in conjunction with maternal toxicity.
Neurotoxicity
BETA-CYFLUTHRIN TECHNICAL
In acute and subchronic neurotoxicity screening studies in rats, beta-cyfluthrin
produced slight transient neurobehavioral effects in each study at the highest
dose tested. There were no correlating morphological changes in neural tissues
in either study.
IMIDACLOPRID TECHNICAL
In acute and subchronic neurotoxicity screening studies in rats, imidacloprid
produced slight neurobehavioral effects in each study at the highest dose tested.
There were no correlating morphological changes observed in the neural tissues.